FDA Commissioner: Addressing Revolving Door Between Agency & Pharma is a 'Delicate Area'

FDA Commissioner Dr. Robert Califf Says Addressing the Revolving Door Between the Agency & the Pharmaceutical Industry is a 'Delicate Area'

"There are people who work within the FDA for a period of time. They have skills and knowledge about an area, and it's an issue to say well they could never work in an industry where they might develop a cure for cancer or whatever the thing may be. So this is a delicate area...Yeah I mean there...It's a complicated area...so I'm reluctant to just off the cuff, make a specific recommendation."